Daqiang Sun

Dr. Daqiang Sun


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
LLLei Li
Lei Li
DSDaqiang Sun
Daqiang Sun
XLXiaoping Li
Xiaoping Li
BYBo Yang
Bo Yang
WZWeidong Zhang
Weidong Zhang

1 October 2017 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
XLXuefeng Lin
Xuefeng Lin
YFYichu Fan
Yichu Fan
XWXiaodong Wang
Xiaodong Wang
MCMingyou Chi
Mingyou Chi
XLXin Li
Xin Li
DSDaqiang Sun
Daqiang Sun

17 August 2025 in Scientific Reports
Verified
Journal Article
Open access
SCShizhao Cheng
Shizhao Cheng
HZHao Zhang
Hao Zhang
ZSZhenliang Shi
Zhenliang Shi
DSDaqiang Sun
Daqiang Sun
Lung squamous cell carcinoma (LUSC) is one of the most common types of non-small cell lung cancer with poor prognosis. Druggable genome-wide Mendelian randomization (MR) was conducted to discover LUSC-related targets using expression quantitative trait loci (eQTL) and protein QTL (pQTL) in the ieu_b_4953 dataset and finngen dataset. Bayesian co-localization analysis, summary‑data‑based MR (SMR) analysis, and HEIDI test were conducted to verify the causal associations between genes and LUSC risk. Prediction of prognosis and immune infiltration was performed at the transcriptomic level, and expression patterns of genes were analyzed at the single-cell level. We identified DNMT1, ACSS2, YBX1, SELENOS, PPARA, MST1, CPA4, and MPO as LUSC-related genes based on MR analysis. Although Bayesian co-localization analysis showed negative co-localization results (PPH3 + PPH4 < 0.8), positive SMR (p < 0.05) and HEIDI (p > 0.05) were found in the ieu_b_4953 dataset and finngen dataset. Blood CPA4 and DNMT1 might be protective factors for bladder cancer and allergic rhinitis, respectively. Patients with low expression of CPA4, DNMT1 and YBX1 had better prognosis, while patients with high expression of MST1 had better prognosis. Tumor samples exhibited reduced infiltration of CD4 cells, CD8 cells, activated dendritic cells, eosinophils, myeloid-derived suppressor cells (MDSCs), macrophages, and mast cells. At the single-cell level, DNMT1, SELENOS and YBX1 were highly expressed in endothelial cells, epithelial cells, fibroblasts, hepatocytes, mast cells, and monocytes/macrophages. MST1 was overexpressed in hepatocytes. This study might deepen the understanding of the LUSC pathogenesis and identify potential targets for the management of LUSC.

7 August 2017 in Molecular Medicine Reports
Verified
Journal Article
Closed access
PDF file
XLXuefeng Lin
Xuefeng Lin
ZWZhenlin Wu
Zhenlin Wu
YFYichu Fan
Yichu Fan
MCMingyou Chi
Mingyou Chi
XWXiaodong Wang
Xiaodong Wang
DSDaqiang Sun
Daqiang Sun
Pulmonary surfactant protein A (SP‑A) and pulmonary surfactant protein D (SP‑D) are associated with the pathogenesis of chronic obstructive pulmonary disease (COPD). The aim of the present study was to determine the correlation between SP‑A, SP‑D and lung function in patients with COPD. A total of 60 patients with lung cancer undergoing unilateral lobectomy were selected and divided into three groups, including a non‑COPD group (n=20), a COPD treatment group (n=20) and a COPD control group (n=20). The levels of SP‑A and SP‑D were detected in the exhaled breath condensate (EBC) using ELISA analysis. Tissue samples were obtained during lobectomy via resection of the adjacent lung tissues, located >5 cm from the nodule. Immunohistochemistry and reverse transcription‑quantitative polymerase chain reaction analysis was performed. The proportion of SP‑A+ alveolar type II (ATII) cells and the mRNA levels of SP‑A and SP‑D in lung tissue were measured. In addition, the correlation between SP‑A and SP‑D in EBC, SP‑A and SP‑D mRNA in lung tissue, forced expiratory volume in 1 sec (FEV1) and the ratio of SP‑A+ ATII, was evaluated. The expression levels of SP‑A and SP‑D were significantly increased in patients of the non‑COPD group compared with the other two groups (P0.05). The results of the present study indicated that the SP‑A and SP‑D levels in EBC were correlated with lung function, which contributed to COPD diagnosis. Future studies are required to further investigate the results of the present study.

22 December 2015 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
XLXue-Feng Lin
Xue-Feng Lin
LZLei Zhang
Lei Zhang
SSShu-Yuan Shi
Shu-Yuan Shi
YFYi-Chu Fan
Yi-Chu Fan
ZWZhen-Lin Wu
Zhen-Lin Wu
DSDaqiang Sun
Daqiang Sun
Pulmonary surfactant protein A (SP-A) has been associated with host defense in the lung, and contributes to the pathogenesis of chronic obstructive pulmonary disease (COPD). The present study aimed to determine a non‑invasive method of measurement of SP‑A, and further examine the expression levels of SP‑A in patients with COPD. SP‑A was detected in the exhaled breath condensate (EBC) obtained from patients with COPD and from non‑COPD subjects. The individuals recruited for the present study comprised 60 subjects with and without COPD, who underwent lobectomy for a solitary peripheral lung nodule. EBC was collected using a condenser, and an enzyme‑linked immunosorbent assay (ELISA) was used to measure the levels of SP‑A. Tissue samples were obtained during lobectomy through resection of the adjacent lung tissues, located >5 cm from the nodule. Western blot analysis and immunohistochemistry were used to measure SP‑A and SP‑A‑positive type II pneumocytes. The results demonstrated that SP‑A was detectable in the EBC of all subjects. The results of the ELISA and western blotting demonstrated that the expression levels of SP‑A were significantly decreased in patients with COPD, compared with the non‑COPD subjects. The reduction of SP‑A‑positive type II pneumocytes was associated with the expression levels of SP‑A. Decreased expression levels of SP‑A in EBC were associated with a higher degree of airway limitation. These results suggested that the measurement of SP‑A levels in the EBC may serve as a method for monitoring airway obstruction in patients with COPD. Further investigations are required in order to examine these observations further and to elucidate the underlying mechanisms.